Michelle Munson
Family · Waldorf, MDNPI 1912360181
Payments from drug & device makers
Across 231 payments — averaging $22.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$956
- AstraZeneca$865
- GSK$768
- Pfizer$327
- Genentech USA, Inc.$282
- Regeneron Healthcare Solutions, Inc.$279
- plus $2K from 18 others
What the payments were for
- Food & beverage$5,132100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 44 | $956 |
| AstraZeneca | 39 | $865 |
| GSK | 37 | $768 |
| Pfizer | 15 | $327 |
| Genentech USA, Inc. | 10 | $282 |
| Regeneron Healthcare Solutions, Inc. | 11 | $279 |
| Grifols USA, LLC | 13 | $250 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $234 |
| Aimmune Therapeutics, Inc. | 5 | $218 |
| Amgen | 9 | $205 |
| Kaleo, Inc. | 8 | $144 |
| Optinose US, Inc. | 9 | $143 |
| Alk-abello, Inc | 5 | $110 |
| Biocryst US Sales Co., LLC | 3 | $81 |
| LEO Pharma Inc. | 3 | $76 |
| Novartis | 2 | $40 |
| Novo Nordisk | 2 | $34 |
| AbbVie | 1 | $22 |
| Exact Sciences | 1 | $21 |
| Teva Pharmaceuticals USA, Inc. | 1 | $20 |
| Verona Pharma, Inc. | 1 | $19 |
| Blueprint Medicines Corporation | 1 | $14 |
| Johnson & Johnson | 1 | $12 |
| Lilly USA, LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PALFORZIA$125
How this compares
$5,132 in reported general payments places this provider in the 90th percentile of 2,843 family providers in Maryland.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ipratropium Bromide | 14 | $469 |
| Azelastine Hcl | 13 | $460 |
| Levocetirizine Dihydrochloride | 11 | $199 |
Paid to pharmacies, not to this prescriber.
Other family in Waldorf
- Laure GoudiabyWaldorf$21K
- Ariana ChaoLutherville$727K
- Erika HoffmanPotomac$226K
- Caroline MansySalisbury$106K
- Hazel Jones-ParkerBaltimore$96K
- Brittany WilsonBaltimore$88K
- Meredith SagalHunt Valley$82K
- Sharon Dudley-BrownBel Air$67K
- Joy MaulikSalisbury$47K
- Kristin AttiogbeChevy Chase$42K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.